{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:14:11Z","timestamp":1761808451318},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T00:00:00Z","timestamp":1619222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>To discuss the role of catheter ablation in treating life-threatening ventricular arrhythmias associated with Brugada syndrome (BrS), by presenting recent findings of BrS arrhythmogenic substrate, mechanisms underlying ventricular arrhythmias, and how they can be treated with catheter ablation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>Almost three decades ago when the clinical entity of Brugada syndrome (BrS) was described in patients who had abnormal coved-type ST elevation in the right precordial EKG leads in patients who had no apparent structural heart disease but died suddenly from ventricular fibrillation. Since its description, the syndrome has galvanized explosive research in this field over the past decades, driving major progress toward better understanding of BrS, gaining knowledge of the genetic pathophysiology and risk stratification of BrS, and creating significant advances in therapeutic modalities. One of such advances is the ability for electrophysiologists to map and identify the arrhythmogenic substrate sites of BrS, which serve as good target sites for catheter ablation. Subsequently, several studies have shown that catheter ablation of these substrates normalizes the Brugada ECG pattern and is very effective in eliminating these substrates and preventing recurrent VF episodes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>Catheter ablation has become an important addition for treatment of symptomatic BrS patients with recurrent VT\/VF episodes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11886-021-01479-2","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T05:08:45Z","timestamp":1619327325000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Role of Catheter Ablation for Ventricular Arrhythmias in Brugada Syndrome"],"prefix":"10.1007","volume":"23","author":[{"given":"Ronpichai","family":"Chokesuwattanaskul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koonlawee","family":"Nademanee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,24]]},"reference":[{"issue":"6","key":"1479_CR1","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","volume":"20","author":"P Brugada","year":"1992","unstructured":"Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20(6):1391\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"1479_CR2","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1161\/01.CIR.0000034169.45752.4A","volume":"106","author":"AA Wilde","year":"2002","unstructured":"\u2022 Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, et al. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation. 2002;106:2514\u20139 The first consensus report that has created the criteria of BrS diagnosis.","journal-title":"Circulation"},{"key":"1479_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1161\/01.CIR.0000152479.54298.51","volume":"111","author":"C Antzelevitch","year":"2005","unstructured":"\u2022 Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111:659\u201370 The second consensus report that has expanded the diganostic criteria, risk stratification, and management of BrS.","journal-title":"Circulation"},{"issue":"10","key":"1479_CR4","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/europace\/eut272","volume":"15","author":"SG Priori","year":"2013","unstructured":"\u2022 Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace. 2013;15(10):1389\u2013406 An expert consensus of how one best diagnose and manage BrS.","journal-title":"Europace"},{"issue":"9","key":"1479_CR5","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jacc.2018.06.037","volume":"72","author":"J Brugada","year":"2018","unstructured":"Brugada J, Campuzano O, Arbelo E, Sarquella-Brugada G, Brugada R. Present status of Brugada syndrome. J Am Coll Cardiol. 2018;72(9):1046\u201359.","journal-title":"J Am Coll Cardiol"},{"key":"1479_CR6","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1253\/circj.CJ-12-1352","volume":"76","author":"G Veerakul","year":"2012","unstructured":"Veerakul G, Nademanee K. Brugada syndrome: two decades of progress. Circ J. 2012;76:2713\u201322.","journal-title":"Circ J"},{"issue":"12","key":"1479_CR7","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","volume":"123","author":"K Nademanee","year":"2011","unstructured":"Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011;123(12):1270\u20139.","journal-title":"Circulation."},{"issue":"18","key":"1479_CR8","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.jacc.2015.08.862","volume":"66","author":"K Nademanee","year":"2015","unstructured":"\u2022\u2022 Nademanee K, Raju H, de Noronha SV, Papadakis M, Robinson L, Rothery S, et al. Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome. J Am Coll Cardiol. 2015;66(18):1976\u201386 The first paper to correlate myocardial fibrosis, arrhythmogenic substrates that harbor abnormal fractionated electrograms and the beneficial effects of ablation over these fibrotic areas.","journal-title":"J Am Coll Cardiol"},{"key":"1479_CR9","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1161\/CIRCULATIONAHA.105.532614","volume":"112","author":"R Coronel","year":"2005","unstructured":"Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJ, Verkerk AO, de Groot JR, et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation. 2005;112:2769\u201377.","journal-title":"Circulation"},{"key":"1479_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1161\/CIRCEP.109.904763","volume":"3","author":"JM de Bakker","year":"2010","unstructured":"de Bakker JM, Wittkampf FH. The pathophysiologic basis of fractionated and complex electrograms and the impact of recording techniques on their detection and interpretation. Circ Arrhythm Electrophysiol. 2010;3:204\u201313.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1479_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","volume":"59","author":"SG Priori","year":"2012","unstructured":"Priori SG, Gasparini M, Napolitano C, Della Bella P, Ottonelli AG, Sassone B, et al. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol. 2012;59:37\u201345.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1479_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1161\/CIRCEP.114.002647","volume":"8","author":"J Sieira","year":"2015","unstructured":"Sieira J, Conte G, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, et al. Prognostic value of programmed electrical stimulation in Brugada syndrome: 20 years experience. Circ Arrhythm Electrophysiol. 2015;8(4):777\u201384.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1479_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/hc0102.101354","volume":"105","author":"J Brugada","year":"2002","unstructured":"Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-Term Follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation. 2002;105:78.","journal-title":"Circulation"},{"issue":"5","key":"1479_CR14","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1161\/CIRCEP.114.003044","volume":"8","author":"J Sieira","year":"2015","unstructured":"Sieira J, Ciconte G, Conte G, Chierchia GB, de Asmundis C, Baltogiannis G, et al. Asymptomatic Brugada syndrome: clinical characterization and long-term prognosis. Circ Arrhythm Electrophysiol. 2015;8(5):1144\u201350.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"41","key":"1479_CR15","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"\u2022\u2022 Priori SG, Blomstrom-Lundqvist C. European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs. Eur Heart J. 2015;36(41):2757\u20139 This paper provides the evidence-based guidelines for management and prevention of Brugada syndrome.","journal-title":"Eur Heart J"},{"key":"1479_CR16","first-page":"S_982","volume":"118","author":"G Veerakul","year":"2008","unstructured":"Veerakul G, Camblock J, Schwab M, Nademanee K. Low mortality rate among asymptomatic Brugada syndrome patients: a multicenter control-randomized study comparing ICD-versus no-ICD treatment. Circulation. 2008;118:S_982.","journal-title":"Circulation"},{"key":"1479_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","volume":"121","author":"V Probst","year":"2010","unstructured":"Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL, et al. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry. Circulation. 2010;121:635\u201343.","journal-title":"Circulation"},{"key":"1479_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCEP.108.816892","volume":"2","author":"S Kamakura","year":"2009","unstructured":"Kamakura S, Ohe T, Nakazawa K, Aizawa Y, Shimizu A, Horie M, et al. Long-term prognosis of probands with Brugada-pattern ST- elevation in leads V1-V3. Circ Arrhythm Electrophysiol. 2009;2:495\u2013503.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1479_CR19","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/eurheartj\/ehm116","volume":"28","author":"M Paul","year":"2007","unstructured":"Paul M, Gerss J, Schulze-Bahr E, Wichter T, Vahlhaus C, Wilde AA, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J. 2007;28:2126\u201333.","journal-title":"Eur Heart J"},{"key":"1479_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/01.CIR.0000153267.21278.8D","volume":"111","author":"L Eckardt","year":"2005","unstructured":"Eckardt L, Probst V, Smits JP, Bahr ES, Wolpert C, Schimpf R, et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation. 2005;111:257\u201363.","journal-title":"Circulation"},{"key":"1479_CR21","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/j.1540-8167.2007.00971.x","volume":"18","author":"M Takagi","year":"2007","unstructured":"Takagi M, Yokoyama Y, Aonuma K, Aihara N, Hiraoka M, Investigators JIVFSJ-I. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan. J Cardiovasc Electrophysiol. 2007;18:1244\u201351.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1479_CR22","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.106.628537","volume":"114","author":"F Sacher","year":"2006","unstructured":"Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-G\u00e9rard F, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation. 2006;114:2317\u201324.","journal-title":"Circulation"},{"key":"1479_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/eurheartj\/ehl450","volume":"28","author":"A Sarkozy","year":"2007","unstructured":"Sarkozy A, Boussy T, Kourgiannides G, Chierchia GB, Richter S, De Potter T, et al. Long-term follow-up of primary prophylactic implantable cardioverter- defibrillator therapy in Brugada syndrome. Eur Heart J. 2007;28:334\u201344.","journal-title":"Eur Heart J"},{"key":"1479_CR24","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1540-8167.2011.02075.x","volume":"22","author":"D Steven","year":"2011","unstructured":"Steven D, Roberts-Thomson KC, Inada K, Seiler J, Koplan BA, Tedrow UB, et al. Long-term follow-up in patients with presumptive Brugada syndrome treated with implanted defibrillators. J Cardiovasc Electrophysiol. 2011;22:1115\u20139.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"1479_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.hrcr.2017.07.005","volume":"3","author":"J Shenthar","year":"2017","unstructured":"Shenthar J, Chakali SS, Acharya D, Parvez J, Banavalikar B. Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy. HeartRhythm Case Rep. 2017;3(10):470\u20134.","journal-title":"HeartRhythm Case Rep"},{"issue":"23","key":"1479_CR26","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.jacc.2013.02.077","volume":"61","author":"S Viskin","year":"2013","unstructured":"Viskin S, Wilde AA, Guevara-Valdivia ME, Daoulah A, Krahn AD, Zipes DP, et al. Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries. J Am Coll Cardiol. 2013;61(23):2383\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1479_CR27","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1161\/01.CIR.0000066319.56234.C8","volume":"107","author":"K Nademanee","year":"2003","unstructured":"Nademanee K, Veerakul G, Mower M, Likittanasombat K, Krittayapong R, Bhuripanyo K, et al. Defibrillator Versus beta-Blockers for Unexplained Death in Thailand (DEBUT): a randomized clinical trial. Circulation. 2003;107:2221\u20136.","journal-title":"Circulation"},{"issue":"3","key":"1479_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.hrthm.2016.12.001","volume":"14","author":"K Nademanee","year":"2017","unstructured":"\u2022 Nademanee K, Hocini M, Ha\u00efssaguerre M. Epicardial substrate ablation for Brugada syndrome. Heart Rhythm. 2017;14(3):457\u201361 This paper gives an overview and rationale of catheter ablation of BrS.","journal-title":"Heart Rhythm"},{"issue":"8","key":"1479_CR29","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1161\/01.CIR.0000088781.99943.95","volume":"108","author":"M Haissaguerre","year":"2003","unstructured":"Haissaguerre M, Extramiana F, Hocini M, Cauchemez B, Jais P, Cabrera JA, et al. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation. 2003;108(8):925\u20138.","journal-title":"Circulation."},{"key":"1479_CR30","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1161\/CIRCEP.115.003220","volume":"8","author":"J Brugada","year":"2015","unstructured":"Brugada J, Pappone C, Berruezo A, Vicedomini G, Manguso F, Ciconte G, et al. Brugada syndrome phenotype elimination by epicardial substrate ablation. Circ Arrhythm Electrophysiol. 2015;8:1373\u201381.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1479_CR31","doi-asserted-by":"publisher","first-page":"e005053","DOI":"10.1161\/CIRCEP.117.005053","volume":"10","author":"C Pappone","year":"2017","unstructured":"Pappone C, Brugada J, Vicedomini G, et al. Electrical substrate elimination in 135 consecutive patients with Brugada syndrome. Circ Arrhythm Electrophysiol. 2017;10:e005053.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1479_CR32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.hrthm.2017.01.006","volume":"14","author":"FP Chung","year":"2017","unstructured":"Chung FP, Raharjo SB, Lin YJ, Chang SL, Lo LW, Hu YF, et al. A novel method to enhance phenotype, epicardial functional substrates, and ventricular tachyarrhythmias in Brugada syn- drome. Heart Rhythm. 2017;14:508\u201317.","journal-title":"Heart Rhythm"},{"key":"1479_CR33","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.hrthm.2018.03.019","volume":"15","author":"GC Fernandes","year":"2018","unstructured":"Fernandes GC, Fernandes A, Cardoso R, Nasi G, Rivera M, Mitrani RD, et al. Ablation strategies for the management of symptomatic Brugada syndrome: a systematic review. Heart Rhythm. 2018;15:1140\u20137.","journal-title":"Heart Rhythm"},{"key":"1479_CR34","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.hrthm.2016.07.025","volume":"13","author":"P Zhang","year":"2016","unstructured":"Zhang P, Tung R, Zhang Z, Sheng X, Liu Q, Jiang R, et al. Characterization of the epicardial substrate for catheter ablation of Brugada syndrome. Heart Rhythm. 2016;13:2151\u20138.","journal-title":"Heart Rhythm"},{"key":"1479_CR35","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1111\/j.1540-8167.2012.02433.x","volume":"23","author":"B Sunsaneewitayakul","year":"2012","unstructured":"Sunsaneewitayakul B, Yao Y, Thamaree S, Zhang S. Endocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndrome. J Cardiovasc Electrophysiol. 2012;23:S10\u20136.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"8","key":"1479_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.117.005631","volume":"11","author":"AK Talib","year":"2018","unstructured":"Talib AK, Takagi M, Shimane A, Nakano M, Hayashi T, Okajima K, et al. Efficacy of endocardial ablation of drug-resistant ventricular fibrillation in Brugada syndrome: long-term outcome. Circ Arrhythm Electrophysiol. 2018;11(8):e005631.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"1479_CR37","doi-asserted-by":"publisher","first-page":"e0006675","DOI":"10.1161\/CIRCEP.118.006675","volume":"11","author":"K Nademanee","year":"2018","unstructured":"Nademanee K, Ha\u00efssaguerre M. Endocardial ablation approach for Brugada syndrome: an important first step or a Quixotic quest. Circ Arrhythm Electrophysiol. 2018;11(8):e0006675.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1479_CR38","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.jacc.2014.01.072","volume":"63","author":"K Tokioka","year":"2014","unstructured":"Tokioka K, Kusano KF, Morita H, Miura D, Nishii N, Nagase S, et al. Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities. J Am Coll Cardiol. 2014;63:2131\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1479_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1161\/CIRCEP.108.795153","volume":"2","author":"A Sarkozy","year":"2009","unstructured":"Sarkozy A, Chierchia GB, Paparella G, et al. Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome. Circ Arrhythm Electrophysiol. 2009;2:154\u201340.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1479_CR40","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.hrthm.2008.09.021","volume":"5","author":"KP Letsas","year":"2008","unstructured":"Letsas KP, Sacher F, Probst V, et al. Prevalence of early repolarization pattern in inferolateral leads in patients with Brugada syndrome. Heart Rhythm. 2008;5:1685\u20139.","journal-title":"Heart Rhythm"},{"key":"1479_CR41","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCULATIONAHA.118.039022","volume":"140","author":"K Nademanee","year":"2019","unstructured":"\u2022 Nademanee K, Ha\u00efssaguerre M, Hocini, et al. Mapping and ablation of ventricular fibrillation associated with early repolarization syndrome. Circulation. 2019;140:1477\u201390 The first report of catheter ablation of the J wave syndrome substrates that includes the combined BrS and ERS.","journal-title":"Circulation"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01479-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-021-01479-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01479-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T11:45:27Z","timestamp":1620647127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-021-01479-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,24]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1479"],"URL":"https:\/\/doi.org\/10.1007\/s11886-021-01479-2","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,24]]},"assertion":[{"value":"17 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Chokesuwattanaskul declare that he has no conflict of interest. Dr. Nademanee has royalty income and consultant honoraria from Biosense Webster, Inc. and research grants from Biosense Webster, Inc. and Medtronic Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"54"}}